Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot simplification to fosamprenavir/ritonavir monotherapy in virologically suppressed HIV patients
2007-003584-45Phase 3Active
- Sponsor
- Daniel Podzamczer Palter
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of fosamprenavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Daniel Podzamczer Palter. Primary endpoint: Proportion of patients with plasma HIV RNA <40 copies/mL at 12 months. Started Jul 2007; status: active.
02
Drugs
fosamprenavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003584-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003584-45.